Clinical Trials Browser

Adenocarcinoma, Clear Cell × Bevacizumab × Genitourinary × Clear all

NCT00455975 2014-12-22

High-dose Bevacizumab in Advanced Renal Carcinoma Patients

Phase 2 Completed

119 enrolled 8 charts

Kidney Neoplasms, Adenocarcinoma, Clear Cell